Skip to main content
Clinical Trials/NCT04459039
NCT04459039CompletedNot Applicable

Do We Need Fluid Restriction After Stapled Hemorrhoidopexy? A Pilot, Double-Blinded, Randomized Controlled Trial

Tri-Service General Hospital1 site in 1 country53 target enrollmentStarted: February 1, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
53
Locations
1
Primary Endpoint
first urination

Study Overview

Brief Summary

BACKGROUND: Conventional hemorrhoidectomy leads to a high urinary retention rate and fluid restriction is commonly recommended to minimize complications. However, the need for postoperative fluid restriction among patients who have undergone stapled hemorrhoidopexy is unclear. We aimed to determine whether fluid restriction after stapled hemorrhoidopexy with/without partial external hemorrhoidectomy could reduce urinary retention and postoperative pain.

PATIENTS AND METHODS: In this prospective, double-blinded, randomized controlled trial, we enrolled patients who had grade III or IV hemorrhoids and underwent stapled hemorrhoidopexy with/without partial external hemorrhoidectomy; 250 mL/12 h of sterile 0.9% saline was administered to the fluid restriction group after the operation, and 1000 mL/12 h was given to the non-fluid-restriction group. We focused on the need for fluid restriction after stapled hemorrhoidopexy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
20 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Gr. III-IV hemorrhoids paitents

Exclusion Criteria

  • Age<20 or >80
  • Allergy to NSAID or opoids
  • Impaired renal function
  • Pregnant or breast feeding

Arms & Interventions

Fluid restriction

Experimental

Within 12 h of surgery, the experimental group received 1000 mL 0.9% sterile saline intravenously.

Intervention: 1000 mL 0.9% sterile saline (Drug)

Non-fluid restriction

Placebo Comparator

Within 12 h of surgery, the control group received 250 mL 0.9% sterile saline intravenously

Intervention: 250 mL 0.9% sterile saline (Drug)

Outcomes

Primary Outcomes

first urination

Time Frame: 1 day

the time to first urination after surgery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yi-Chiao Cheng

Division of Colon and Rectal Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center

Tri-Service General Hospital

Study Sites (1)

Loading locations...

Similar Trials